Gabelli Healthcare (NYSE: GRX) holder lifts stake above 2.15M shares

Rhea-AI Filing Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, purchased 4,340 shares of common stock on August 27, 2026, in an open-market or private transaction at $10.05 per share. Following this indirect ownership purchase, Saba Capital Management reports holding 2,155,133 common shares of GRX.

Insider Trade Summary

Net Buyer: 4,340 shares

Net Buy 1 txn

Insider Saba Capital Management, L.P.

Role 10% Owner

Bought 4,340 shs ($44K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	4,340	$10.05	$44K

Holdings After Transaction: Common Stock — 2,155,133 shares (Indirect, -)

Key Figures

Shares purchased: 4,340 shares of common stock Purchase price per share: $10.05 per share Shares owned after transaction: 2,155,133 shares of common stock

3 metrics

Shares purchased 4,340 shares of common stock Non-derivative purchase on August 27, 2026

Purchase price per share $10.05 per share Price for the 4,340 GRX shares purchased

Shares owned after transaction 2,155,133 shares of common stock Indirect ownership reported after the purchase

Key Terms

ten percent owner, indirect ownership, open market or private transaction

3 terms

ten percent owner regulatory

"Saba Capital Management, L.P. is reported as a ten percent owner"

indirect ownership financial

"The ownership type for these shares is reported as indirect"

open market or private transaction financial

"Transaction code description notes a purchase in open market or private transaction"

FAQ

Who bought GRX shares in this Form 4 filing?

The filing reports that Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), purchased additional shares of GRX common stock. The position is reported as held through indirect ownership.

How many GRX shares did Saba Capital Management purchase?

Saba Capital Management purchased 4,340 shares of Gabelli Healthcare & WellnessRx Trust (GRX) common stock in this reported transaction. These shares were acquired in a single non-derivative transaction.

At what price were the new GRX shares bought?

The newly acquired GRX shares were purchased at $10.05 per share. The filing describes the transaction code as a purchase in an open market or private transaction.

What is Saba Capital Management’s total GRX holding after this transaction?

After this purchase, Saba Capital Management reports holding 2,155,133 shares of Gabelli Healthcare & WellnessRx Trust (GRX) common stock. This figure reflects the total indirect ownership position following the transaction.

Was this GRX trade under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not affirmed (set to false), indicating the reported GRX share purchase was not designated as made pursuant to a Rule 10b5-1 trading plan in this report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/28/2026 - 10:46 AM Accepted by SEC EDGAR 08/28/2026 - 10:45 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saba Capital Management, L.P.

(Last) (First) (Middle)

405 LEXINGTON AVENUE

58TH FLOOR

(Street)

NEW YORK NEW YORK 10174

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2026		P		4,340	A	$10.05	2,155,133	I	-

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Saba Capital Management, L.P. By: Zachary Gindes	08/28/2026
	Boaz Weinstein	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)